Loading...
Masco Corp is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While there are some positive catalysts like the dividend increase and share buyback program, the recent financial performance shows a decline in revenue, net income, and EPS. Additionally, insider selling and mixed analyst ratings suggest caution. The technical indicators are bullish, but the lack of strong proprietary trading signals and the stock's potential for short-term downside make it less compelling for immediate investment.
The MACD is positive and expanding, indicating bullish momentum. The RSI is in the neutral zone at 75.953. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 77.464), which could act as a barrier for further upward movement. The overall technical trend is bullish, but the stock is nearing overbought conditions.

Q4 earnings beat expectations, leading to a 10% stock surge.
Announcement of a $2 billion share buyback program.
Dividend increase from $0.31 to $0.32 per share.
Insiders are selling, with a 277.37% increase in selling activity over the last month.
Financial performance in Q4 2025 shows declines in revenue (-1.91% YoY), net income (-9.34% YoY), and EPS (-4.76% YoY).
Analysts have mixed ratings, with some downgrades citing valuation concerns.
In Q4 2025, Masco reported a revenue decline of -1.91% YoY to $1.793 billion, net income dropped -9.34% YoY to $165 million, and EPS decreased -4.76% YoY to $0.8. Gross margin also declined to 33.8%, down -2.85% YoY.
Analyst ratings are mixed. Recent downgrades include Zelman lowering to Neutral with an $81 price target, citing valuation concerns. However, Oppenheimer raised the price target to $88 and maintained an Outperform rating, citing favorable Q4 results and a positive outlook. Other firms like Evercore ISI and Wells Fargo have raised price targets but kept cautious ratings.